Literature DB >> 35165866

Cancer Stem Cells: An Ever-Hiding Foe.

Jacek R Wilczyński1.   

Abstract

Cancer stem cells are a population of cells enable to reproduce the original phenotype of the tumor and capable to self-renewal, which is crucial for tumor proliferation, differentiation, recurrence, and metastasis, as well as chemoresistance. Therefore, the cancer stem cells (CSCs) have become one of the main targets for anticancer therapy and many ongoing clinical trials test anti-CSCs efficacy of plenty of drugs. This chapter describes CSCs starting from general description of this cell population, through CSCs markers, signaling pathways, genetic and epigenetic regulation, role of epithelial-mesenchymal transition (EMT) transition and autophagy, cooperation with microenvironment (CSCs niche), and finally role of CSCs in escaping host immunosurveillance against cancer.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer stem cells; Chemoresistance; Epithelial-mesenchymal transition; Metastasis; Niche

Mesh:

Year:  2022        PMID: 35165866     DOI: 10.1007/978-3-030-91311-3_8

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  244 in total

1.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

Review 2.  microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.

Authors:  Zahra Asadzadeh; Behzad Mansoori; Ali Mohammadi; Marjan Aghajani; Khalil Haji-Asgarzadeh; Elham Safarzadeh; Ahad Mokhtarzadeh; Pascal H G Duijf; Behzad Baradaran
Journal:  J Cell Physiol       Date:  2018-12-07       Impact factor: 6.384

Review 3.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 5.  The challenge of targeting cancer stem cells to halt metastasis.

Authors:  Alice Agliano; Alfonso Calvo; Carol Box
Journal:  Semin Cancer Biol       Date:  2017-03-18       Impact factor: 15.707

Review 6.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

7.  Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

Authors:  Brooke Ancrile; Kian-Huat Lim; Christopher M Counter
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

8.  Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids.

Authors:  Richard C Bates; Arthur M Mercurio
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

9.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Authors:  Bahriye Aktas; Mitra Tewes; Tanja Fehm; Siegfried Hauch; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Cancer Res       Date:  2009-07-09       Impact factor: 6.466

10.  Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Authors:  Khalid Abubaker; Rodney B Luwor; Hongjian Zhu; Orla McNally; Michael A Quinn; Christopher J Burns; Erik W Thompson; Jock K Findlay; Nuzhat Ahmed
Journal:  BMC Cancer       Date:  2014-05-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.